Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Monoclonal antibody therapy]

C Pitzalis, N Pipitone, R Marcolongo

    Recenti Progressi in Medicina
    |March 1, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Monoclonal antibodies (mAbs) are targeted therapies used in medicine. While generally well-tolerated short-term, long-term effects and safety require further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Lunar Environment Heliophysics X-ray Imager (LEXI) Mission.

    Space science reviews·2024
    Same author

    The scar: the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias.

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2022
    Same author

    The <i>P. gingivalis</i> Autocitrullinome Is Not a Target for ACPA in Early Rheumatoid Arthritis.

    Journal of dental research·2020
    Same author

    B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure.

    Arthritis & rheumatology (Hoboken, N.J.)·2019
    Same author

    Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema.

    Ocular immunology and inflammation·2019
    Same author

    Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset.

    Lupus·2018
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    See all related articles

    Area of Science:

    • Immunology
    • Pharmacology
    • Oncology

    Background:

    • Monoclonal antibodies (mAbs) are derived from cell clones and target specific antigens (Ag).
    • mAb binding can elicit various biological effects, including neutralization, lysis, and antibody-dependent cellular cytotoxicity (ADCC).

    Purpose of the Study:

    • To review the clinical applications, administration, contraindications, and known effects of monoclonal antibodies.
    • To highlight the need for further research into the long-term safety and efficacy of mAbs.

    Main Methods:

    • Review of existing literature on monoclonal antibody applications and clinical data.
    • Analysis of reported effects, contraindications, and adverse events associated with mAb therapy.

    Main Results:

    Related Experiment Videos

    • mAbs are utilized clinically as immunosuppressants, antineoplastic agents, and for diagnostics.
    • Common administration is via slow intravenous infusion, with dosage varying by mAb.
    • Contraindications include allergic, neoplastic, and infective diseases, alongside conditions like hypertension, cardiac failure, and pregnancy.

    Conclusions:

    • Monoclonal antibodies represent a powerful therapeutic modality with diverse applications.
    • Short-term infusion is typically well-tolerated, with rare side effects like headache or rash.
    • Further studies are essential to fully understand the long-term implications, including potential immune response alterations and neoplasm risks.